Wout De Wispelaere

Employment

• Antoni van Leeuwenhoek Post-doctoral Researcher
  2024 - Present
• Katholieke Universiteit Leuven Post-doctoral researcher
  2024 - Present

Education

• KU Leuven MSc Bioscience Engineering
• KU Leuven BSc Bioscience engineering

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial
  Regina Esi Mensimah Baiden-Amissah, Sandra Tuyaerts, Daniela Annibali +15 more
  Frontiers In Immunology 2026 DOI: 10.3389/fimmu.2026.1794131
  +Save
• Feasibility of a rapid post-mortem tissue donation program to study epithelial ovarian cancer
  Gitte Hoorelbeke, Jonathan Servayge, Wouter Van Den Bogaert +17 more
  International Journal Of Gynecological Cancer 2026 DOI: 10.1016/j.ijgc.2025.103859
  +Save
• Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State
  Youssef El Laithy, Willy Antoni Abreu de Oliveira, Anirudh Pabba +21 more
  Cancer Research 2026 DOI: 10.1158/0008-5472.CAN-24-4165
  +Save
• GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
  Dhanya Ramachandran, Xue Min Wang, Triin Laisk +71 more
  Ebiomedicine 2025 DOI: 10.1016/j.ebiom.2025.105830
  +Save
• PETITE Collection: An Ex Vivo Platform For Personalized Therapeutic Testing In Gynaecological Cancers
  Alejandro Herreros‐Pomares, Rossana Benedetto, Wout De Wispelaere +14 more
  International Journal Of Gynecological Cancer 2025 DOI: 10.1016/j.ijgc.2024.101475
  +Save
• EXPLOITING THE IMMUNOMODULATORY EFFECTS OF PI3K/MTOR INHIBITORS TO SENSITIZE UTERINE LEIOMYOSARCOMAS TO IMMUNE CHECKPOINT BLOCKADE
  2024
  +Save
• PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD‐1 blockade
  Wout De Wispelaere, Daniela Annibali, Sandra Tuyaerts +24 more
  Clinical and Translational Medicine 2024 DOI: 10.1002/ctm2.1655
  +Save
• Chemotherapy-treated breast cancer cells activate the Wnt signaling pathway to enter a diapause-DTP state
  2024 DOI: 10.1101/2024.03.08.584051
  +Save
• 17P Exploiting the immune-modulatory effects of PI3K/mTOR inhibitors to enhance response to immune-checkpoint blockade in uterine leiomyosarcoma
  Abstract Book of the ESMO Sarcoma & Rare Cancers 20-22 March 2023, Lugano, Switzerland 2023
  +Save
• 2022-RA-953-ESGO Serine metabolism remodeling after platinum-based chemotherapy is a new vulnerability in resistant ovarian cancer patients
  Tom Van Nyen, Mélanie Planque, Lilian van Wagensveld

  +14 more

  • Esther A. Zaal
  • Lara Rizzotto
  • Wout De Wispelaere
  • Ali Talebi
  • Pierre-René Körner
  • +9 more
  Ovarian cancer 2022 DOI: 10.1136/ijgc-2022-esgo.605
  +Save
• Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers
  Tom Van Nyen, Mélanie Planque, Lilian van Wagensveld +22 more
  Nature Communications 2022 DOI: 10.1038/s41467-022-32272-6
  +Save
• Next generation point-of-care test for therapeutic drug monitoring of adalimumab in patients diagnosed with autoimmune diseases
  Henry Ordutowski, Francesco Dal Dosso, Wout De Wispelaere

  +6 more

  • Charlotte Van Tricht
  • Séverine Vermeire
  • Nick Geukens
  • Ann Gils
  • Dragana Spasić
  • +1 more
  Biosensors & Bioelectronics 2022 DOI: 10.1016/j.bios.2022.114189
  +Save
• The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma
  Raul Maia Falcão, Georgia Kokaraki, Wout De Wispelaere

  +5 more

  • Frédéric C. Amant
  • Gustavo A. de Souza
  • Jorge Estefano Santana de Souza
  • Joseph W. Carlson
  • Tirzah Braz Petta Lajus
  Cancers 2022 DOI: 10.3390/cancers14205007
  +Save
• Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
  Wout De Wispelaere, Daniela Annibali, Sandra Tuyaerts +2 more
  Cancers 2021 DOI: 10.3390/cancers13092040
  +Save
• Expanding the potential of self-powered microfluidics by combining fluid modules for blood sample preparation, drug delivery and complex liquid manipulation
  Expanding the potential of self-powered microfluidics by combining fluid modules for blood sample preparation, drug delivery and complex liquid manipulation 2018
  +Save
• 17P Exploiting the immune-modulatory effects of PI3K/mTOR inhibitors to enhance response to immune-checkpoint blockade in uterine leiomyosarcoma
  Abstract Book of the ESMO Sarcoma & Rare Cancers 20-22 March 2023, Lugano, Switzerland
  +Save
• Germline copy number variants and endometrial cancer risk
  Cassie E. Stylianou, George A. R. Wiggins, V. Lau +47 more
  Human Genetics DOI: 10.1007/s00439-024-02707-9
  +Save